Conservative surgical treatment combined with GnRH agonist in symptomatic uterine adenomyosis

This retrospective study evaluated the safety and therapeutic efficacy of combining conservative surgery with gonadotropin-releasing hormone agonist therapy for patients suffering from symptomatic uterine adenomyosis. The research analyzed data from eighteen women treated at Cheil General Hospital and Women’s Medical Center to assess clinical outcomes following this combined intervention approach. The authors concluded that this treatment strategy is a safe and effective option for preserving fertility while managing symptoms associated with the condition. Relevance to endometriosis: This paper is centrally about adenomyosis, which is closely related to endometriosis as both involve ectopic endometrial-like tissue, though the study focuses specifically on adenomyosis management rather than endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works